These quotes are very impressive from two well known members of Medibio's Growth & Advocacy Advisory Board.
Former U.S. Representative Patrick J. Kennedy:
“Medibio’s technology is truly groundbreaking and has the potential to fundamentally change the mental health system for the better. That’s why I am proud to be part of this team,” said Kennedy. “This is a company that is truly on the cutting edge, and their diagnostic and analytic tools will give clinicians the power to treat patients more effectively, using better data, and with a focus on better outcomes.”
Former Olympian Michael Phelps:
“I am honored to accept this appointment because I have personally experienced Medibio’s technology and believe it can help make a profound impact in diagnosing mental health and empowering people to seek the help and support they may need” said Phelps. “In sports, there is so much focus on the physical aspects of performance, and athletes are analyzed from head to toe. But for many athletes, mental health has not been a topic of focus, and the data analysis aspect of it has been missing up until now. I personally suffered from mental health challenges from my teenage years on, and only fairly recently—after reaching a point of desperation—did I acquire the understanding, treatment, and support I needed, which has truly changed my life. For me, self-awareness, from a mental health standpoint, is empowerment. But I’ve seen firsthand—in sports and beyond—how difficult it is for people to understand, discuss, and confront stress, anxiety, and mental health concerns, all of which can seem like an insurmountable barrier to getting the help and support that is needed. I feel that the ease and objectivity with which Medibio’s technology can accurately help to diagnose mental health will make a profound difference in people’s lives. I want to help others who are dealing with these challenges and make the process for them to take action easier and more understandable.”
- Forums
- ASX - By Stock
- TRI
- FDA Approval - before 29 July
FDA Approval - before 29 July, page-79
-
- There are more pages in this discussion • 285 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
|
|||||
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.45M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 1066091 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 0.038 |
1 | 21 | 0.036 |
2 | 367207 | 0.034 |
1 | 151514 | 0.033 |
1 | 30000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 1066091 | 5 |
0.037 | 863011 | 5 |
0.038 | 420000 | 3 |
0.039 | 485606 | 3 |
0.040 | 432529 | 6 |
Last trade - 09.50am 25/07/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online